<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Earnings report on FinanClub</title>
    <link>https://finan.club/tags/earnings-report/</link>
    <description>Recent content in Earnings report on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 29 Dec 2023 09:01:34 +0000</lastBuildDate><atom:link href="https://finan.club/tags/earnings-report/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>TGTX</title>
      <link>https://finan.club/us/tgtx/</link>
      <pubDate>Fri, 29 Dec 2023 09:01:34 +0000</pubDate>
      
      <guid>https://finan.club/us/tgtx/</guid>
      <description>score:89
Chances: TG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93. The average of price targets set by Wall Street analysts indicates a potential upside of 127.8% in TG Therapeutics (TGTX). The company&amp;rsquo;s Q3 results were very good, with sales figures exceeding expectations.</description>
    </item>
    
  </channel>
</rss>
